Discover

GMED
Globus Medical, Inc.
75.50
1 x 75.51
1 x 75.54
bid
ask
-
0.59
0.78%
2 @ 04:57 PM
75.50 +0.00 (0.00%)
Ytd-13.53%
1y42.43%
75.18
day range
76.45
51.79
52 week range
101.40
Open75.57Prev Close76.09Low75.18High76.45Mkt Cap10.98B
Vol982.77KAvg Vol1.84MEPS4.41P/E18.35Forward P/E17.30
Beta0.95Short Ratio4.06Inst. Own101.59%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg80.27200-d Avg82.891yr Est107.00
Earning
DateForEstimateReportedSurprisesurprise %
2026-08-062026-061.12N/AN/AN/A
2026-05-072026-030.921.120.221.74%
2026-02-242025-121.061.280.2220.75%
2025-11-062025-090.781.180.451.09%
2025-08-072025-060.760.860.113.16%
2025-05-082025-030.740.68-0.06-8.60%
Upgrade / Downgrade
DateFirmActionFromTo
2026-07-09BMO CapitalUpgradeOutperform
2026-07-08StifelUpgradeHoldHold
2026-06-15Piper SandlerUpgradeOverweightOverweight
2026-05-08RBC CapitalUpgradeOutperformOutperform
2026-05-08Wells FargoUpgradeOverweightOverweight
2026-05-08NeedhamUpgradeBuyBuy
Profile
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Insider Holder
DateNameRelationQuantityDescription
2026-06-04DAVIDAR DAVID DDirector676.14KConversion of Exercise of derivative security
2026-02-24HULLER KELLY GRACEGeneral Counsel0.00Conversion of Exercise of derivative security
2026-01-07KLINE KYLEChief Financial Officer0.00Conversion of Exercise of derivative security
2024-11-21LEMAITRE DANIELDirector0.00Conversion of Exercise of derivative security
2026-01-07NORWALK LESLIE VDirector10.42KSale
2025-12-07PAUL DAVID COfficer, Director and Beneficial Owner60.42KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2025-12-30Vanguard Group Inc10.55M0.007.80%
2026-03-30BlackRock Inc10.50M0.007.76%
2026-03-30HHG PLC7.62M0.005.64%
2026-03-30Vanguard Capital Management, LLC5.03M0.003.72%
2026-03-30Vanguard Portfolio Management, LLC4.88M0.003.61%
2026-03-30Amvescap Plc.4.32M0.003.19%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-05-28iShares Core S&P Mid-Cap ETF3.78M0.002.80%
2026-04-29Vanguard Total Stock Mkt Idx Inv3.59M0.002.65%
2026-04-29Vanguard Small Cap Index2.59M0.001.92%
2025-09-29Janus Henderson Mid Cap Growth MA2.21M0.001.63%
2026-03-30Janus Henderson Enterprise D2.21M0.001.63%
2026-03-30Janus Inst Mid Cap Growth CF2.21M0.001.63%